2018 IPCR Presentations

Institute for Prostate Cancer Research (IPCR)

2018 IPCR Presentations

At the IPCR Symposium on April 28, 2018, Fred Hutch researchers and UW Medicine clinicians shared new discoveries in the field of prostate cancer. Sessions covered prostate cancer disparities, risk, quality of life, new imaging biomarkers and treatments, immunotherapy and a prostate cancer tumor board. Read an article about the event here

Welcome

Dr. Peter Nelson

Prostate Cancer: Disparity, Risk & Quality of Life

Racial disparities in prostate cancer – time to make a difference, Dr. Ruth Etzioni
Inherited Risk: GENTleMEN, Dr. Heather Cheng
Diet and Prostate Cancer, Dr. Marian Neuhouser
Exercise Interventions and Prostate Cancer, Dr. Jonathan Wright
Enhancing Quality of Life, Dr. Niels Johnsen
Prostate Cancer: Disparity, Risk and Quality of Life Q & A

 New Imaging Biomarkers and Treatment Implications

The New Pathology (Light Sheet). Dr. Larry True & Dr. Nick Reder
PET Imaging: A Window Into New Treatment Opportunities, Dr. Manuela Matesan
Oligometastatic Prostate Cancer – Current Data/Ongoing Studies, Dr. Dan Lin
Targeted Radiation Therapy: Local Recurrence/Distant Metastasis, Dr. Jing Zeng
New Imaging Biomarkers and Treatment Implications Q & A

Advances in Treating Advanced Prostate Cancer

 

Improving Survival with Combination Therapy, Dr. Michael Schweizer
Immunotherapy: State of the Field + CART, Dr. John Lee
Prostate Cancer Tumor Board (2 cases), Dr. Bruce Montgomery & Dr. Evan Yu
Advances in Treating Advanced Prostate Cancer Q & A
Closing, Dr. Peter Nelson